These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 4402118)
21. Tyrosine 3-monooxygenase from bovine adrenal medulla. Nagatsu T; Oka K Methods Enzymol; 1987; 142():56-62. PubMed ID: 2885718 [No Abstract] [Full Text] [Related]
22. Tissue fractionation and catecholamines. 3. Intracellular distribution of endogenous inhibitors of dopamine- -hydroxylase in adrenal medulla. Belpaire F; Laduron P Biochem Pharmacol; 1970 Apr; 19(4):1323-31. PubMed ID: 4935768 [No Abstract] [Full Text] [Related]
23. Kinetic properties of tyrosine hydroxylase purified from bovine adrenal medulla and bovine caudate nucleus. Oka K; Ashiba G; Sugimoto T; Matsuura S; Nagatsu T Biochim Biophys Acta; 1982 Sep; 706(2):188-96. PubMed ID: 6127111 [No Abstract] [Full Text] [Related]
24. Intracellular distribution of endogenous inhibitors of dopamine -hydroxylase in bovine adrenal medulla. Kuzuya H; Negatsu T Biochem Pharmacol; 1972 Mar; 21(5):740-2. PubMed ID: 5063171 [No Abstract] [Full Text] [Related]
25. Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. Fibiger HC; Mogeer EG Eur J Pharmacol; 1971 Oct; 16(2):176-80. PubMed ID: 4405780 [No Abstract] [Full Text] [Related]
26. Some chemical and physical properties of the soluble protein fraction of bovine adrenal chromaffin granules. Helle KB Mol Pharmacol; 1966 Jul; 2(4):298-310. PubMed ID: 5968070 [No Abstract] [Full Text] [Related]
28. Activation of bovine adrenal tyrosine hydroxylase by ATP. Morita K Tokushima J Exp Med; 1981 Jun; 28(1-2):1-7. PubMed ID: 6170132 [No Abstract] [Full Text] [Related]
29. Tissue fractionation and catecholamines. I. Latency and activation properties of dopamine-beta-hydroxylase in adrenal medulla. Belpaire F; Laduron P Biochem Pharmacol; 1968 Mar; 17(3):411-21. PubMed ID: 5661653 [No Abstract] [Full Text] [Related]
30. Assay of tyrosine hydroxylase by coupled decarboxylation of DOPA formed from 1- 14 C-L-tyrosine. Waymire JC; Bjur R; Weiner N Anal Biochem; 1971 Oct; 43(2):588-600. PubMed ID: 4400965 [No Abstract] [Full Text] [Related]
31. Tyrosine hydroxylase inhibition in vitro and in vivo by deoxyfrenolicin. Taylor RJ; Stubbs CS; Ellenbogen L Biochem Pharmacol; 1970 May; 19(5):1737-41. PubMed ID: 5513953 [No Abstract] [Full Text] [Related]
33. Kinetic properties of brain tyrosine hydroxylase and its partial purification by affinity chromatography. Poillon WN Biochem Biophys Res Commun; 1971 Jul; 44(1):64-70. PubMed ID: 4398956 [No Abstract] [Full Text] [Related]
34. The inhibition of phenylalanine and tyrosine hydroxylases by high oxygen levels. Fisher DB; Kaufman S J Neurochem; 1972 May; 19(5):1359-65. PubMed ID: 4401997 [No Abstract] [Full Text] [Related]
35. Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. Friedman PA; Kappelman AH; Kaufman S J Biol Chem; 1972 Jul; 247(13):4165-73. PubMed ID: 4402511 [No Abstract] [Full Text] [Related]
36. Evidence for an extragranular localization of tyrosine hydroxylase. Laduron P; Belpaire F Nature; 1968 Mar; 217(5134):1155-6. PubMed ID: 5643089 [No Abstract] [Full Text] [Related]
37. The role of pterin cofactor in the regulation of catecholamine synthesis. Weiner N Psychopharmacol Bull; 1978 Oct; 14(4):40-4. PubMed ID: 30112 [No Abstract] [Full Text] [Related]
38. Effect of chlorpromazine free radical on tyrosine hydroxylase of bovine adrenal medulla. Mostafa MH; el-Sewedy SM; Rakonczay Z Agressologie; 1979; 20(5):275-7. PubMed ID: 12679958 [TBL] [Abstract][Full Text] [Related]